Comanagement of Rashes by Primary Care Providers and Dermatologists: A Retrospective Study.
Journal
The Permanente journal
ISSN: 1552-5775
Titre abrégé: Perm J
Pays: United States
ID NLM: 9800474
Informations de publication
Date de publication:
13 12 2021
13 12 2021
Historique:
received:
18
12
2020
accepted:
18
08
2021
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
5
4
2022
Statut:
epublish
Résumé
There is a high demand for managing skin disease, and dermatologists are in short supply. To better understand how rashes and other specific skin conditions are co-managed by primary care providers (PCPs) and dermatologists, we estimated the frequency with which PCPs sought consultation with or referral to dermatology and the proportion of patients who had a follow-up dermatology office visit in the following 90 days. The retrospective longitudinal study included 106,459 patients with a skin condition diagnosed by 3,830 PCPs, from January 2017 to March 2017. Comprehensive electronic medical record data with generalized linear mixed modeling accounted for patient factors including diagnosis and clustering by medical center and PCP. PCPs escalated 9% of patients to dermatology through consultation or referral, while 5% required a follow-up dermatology office visit within 90 days. Patients with bullous, hair, or pigment conditions or psoriasis were most likely to be escalated. Clustering of escalation and follow-up visits was minimal in relation to medical center (intraclass correlation, 0.04 for both outcomes) or PCP (escalation, intraclass correlation, 0.16; follow-up visits, 0.09). Improving primary care education in skin disease and, for certain skin conditions, standardizing approaches to workup, treatment, and escalation may further streamline care and reduce pressure on the dermatologist workforce. PCPs managed 91% of rashes without consultation or referral to dermatology, and the frequency of patients scheduled for dermatology office visits after primary care was similar from one PCP to another.
Sections du résumé
BACKGROUND
There is a high demand for managing skin disease, and dermatologists are in short supply.
OBJECTIVES
To better understand how rashes and other specific skin conditions are co-managed by primary care providers (PCPs) and dermatologists, we estimated the frequency with which PCPs sought consultation with or referral to dermatology and the proportion of patients who had a follow-up dermatology office visit in the following 90 days.
DESIGN AND SETTING
The retrospective longitudinal study included 106,459 patients with a skin condition diagnosed by 3,830 PCPs, from January 2017 to March 2017.
METHODS
Comprehensive electronic medical record data with generalized linear mixed modeling accounted for patient factors including diagnosis and clustering by medical center and PCP.
RESULTS
PCPs escalated 9% of patients to dermatology through consultation or referral, while 5% required a follow-up dermatology office visit within 90 days. Patients with bullous, hair, or pigment conditions or psoriasis were most likely to be escalated. Clustering of escalation and follow-up visits was minimal in relation to medical center (intraclass correlation, 0.04 for both outcomes) or PCP (escalation, intraclass correlation, 0.16; follow-up visits, 0.09).
DISCUSSION
Improving primary care education in skin disease and, for certain skin conditions, standardizing approaches to workup, treatment, and escalation may further streamline care and reduce pressure on the dermatologist workforce.
CONCLUSION
PCPs managed 91% of rashes without consultation or referral to dermatology, and the frequency of patients scheduled for dermatology office visits after primary care was similar from one PCP to another.
Identifiants
pubmed: 35348083
doi: 10.7812/TPP/20.320
pmc: PMC8784066
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Cochrane Database Syst Rev. 2020 Aug 18;8:CD012927
pubmed: 32813281
JAMA Dermatol. 2021 Jan 1;157(1):52-58
pubmed: 33206146
PLoS One. 2020 Apr 27;15(4):e0232131
pubmed: 32339203
J Telemed Telecare. 2019 Sep;25(8):493-498
pubmed: 29991315
J Telemed Telecare. 2020 Jun 26;:1357633X20930453
pubmed: 32588723
J Med Internet Res. 2020 Apr 21;22(4):e16700
pubmed: 32314966
J Am Acad Dermatol. 2019 Nov;81(5):1099-1106
pubmed: 30738843
Perm J. 2020 Nov;24:1-4
pubmed: 33482970
Trials. 2018 Oct 24;19(1):583
pubmed: 30355358
J Telemed Telecare. 2020 Apr;26(3):125-131
pubmed: 30301409
JAMA Dermatol. 2016 Jun 1;152(6):655-60
pubmed: 26950334
BMC Fam Pract. 2016 Oct 14;17(1):145
pubmed: 27737638
Fam Pract. 2016 Jun;33(3):274-85
pubmed: 27075028
J Am Acad Dermatol. 2019 Dec;81(6):1446-1452
pubmed: 31415834
Clin Exp Allergy. 2021 Mar;51(3):483-494
pubmed: 33176023
JAMA Dermatol. 2017 May 1;153(5):472-473
pubmed: 28296988
Arch Intern Med. 2012 Jan 23;172(2):163-70
pubmed: 22271124
Health Aff (Millwood). 2018 Dec;37(12):2031-2036
pubmed: 30633678